Clinical Trials List
Protocol NumberBNT3214-01
Not yet recruiting
2026-07-01 - 2029-01-31
Phase I/II
Recruiting1
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 楊景堯 Division of General Internal Medicine
- 吳宗哲 Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- TSUNG-HAO LIU Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 呂理駿 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- Ying-Chun Shen Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 徐偉勛 醫學研究部
- 廖斌志 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Hung-Wei Wang Digestive System Department
- Chang-Fang Chiu Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
83 participants
-
Global
533 participants
